Siemens Ultrasound of Issaquah, WA, has become the latest ultrasound vendor to add tissue harmonic imaging capabilities to its product line. The firm's version, called Ensemble Tissue Harmonic Imaging, will be offered on its premium Sonoline Elegra
Siemens Ultrasound of Issaquah, WA, has become the latest ultrasound vendor to add tissue harmonic imaging capabilities to its product line. The firm's version, called Ensemble Tissue Harmonic Imaging, will be offered on its premium Sonoline Elegra ultrasound scanners.
The new release allows Elegra users to isolate harmonic signal data without the use of contrast agents, according to the firm. Ensemble supports high-frequency imaging and can provide demonstration of breast lesions and superficial images. The system also shows promise in scanning difficult-to-image patients.
Ensemble eliminates the impact of signal artifacts common during high-frequency scanning with its pulse-inversion technology, which isolates harmonic imaging signals, according to Siemens. Combining the harmonic imaging signals with fundamental signal data allows Elegra to yield improvements in tissue contrast and spatial resolution in nearly all radiological applications, the company believes.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.